Altered fatty acid metabolism and potential drugs in DLBCL
Altered fatty acid metabolism and potential drugs in DLBCL. Fatty acids are transported into DLBCL cells via CD36. Fatty acids are finally converted to acetyl-CoA by a series of oxidation reactions and enter the TCA cycle. A product in the TCA cycle, citrate is transported out of mitochondria by CTP. In cytoplasm, citrate and CoASH are converted to acetyl-CoA catalyzed by ACLY. FASN, the key enzyme in fatty acid synthesis, inhibits the activation of PI3K. PI3K phosphorylates PIP2 to PIP3, and then activates AKT/mTOR pathway to promote cell survival. On the contrary, PTEN dephosphorylates PIP3. Fasnall is a selective FASN inhibitor. Metformin is an inhibitor of CD36. TCA: tricarboxylic acid; FAO: fatty acid oxidation; FASN: fatty acid synthesis; α-KG: α-ketoglutarate; ACLY: ATP-citrate lyase; PYR: pyruvate; CTP: citrate transporter protein; PTEN: phosphatase and tensin homologue; mTOR: metabolic regulator mammalian target of rapamycin; CoASH: coenzyme A. PIP3: phosphatidylinositol 3,4,5-trisphosphate; PIP2: phosphatidylinositol 4,5-bisphosphate
Publication
The Metabolism and Immune Environment in Diffuse Large B-Cell Lymphoma (2023) Jianbo Wu, et al. Metabolites. 2023 Jun;13(6). Figure: F3.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | PTEN | PTEN | ncbigene_symbol | PTEN | 5728 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CA | 5290 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CB | 5291 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CD | 5293 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CG | 5294 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R3 | 8503 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R4 | 30849 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R5 | 23533 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R6 | 146850 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R1 | 5295 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R2 | 5296 |
| Homo sapiens | Primates | AKT | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | CD36 | CD36 | ncbigene_symbol | CD36 | 948 |
| Homo sapiens | Primates | FASN | FASN | ncbigene_symbol | FASN | 2194 |
| Homo sapiens | Primates | mTOR | MTOR | ncbigene_symbol | MTOR | 2475 |
| Homo sapiens | Primates | ACLY | ACLY | ncbigene_symbol | ACLY | 47 |
| Homo sapiens | Primates | CTP | CTP | ncbigene_synonym | SLC25A1 | 6576 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Metformin | metformin | N,N-dimethyltriimidodicarbonic diamide | chebi:6801 | |
| Acetyl-CoA | acetyl-CoA | 3'-phosphonatoadenosine 5'-(3-{(3R)-4-[(3-{[2-(acetylsulfanyl)ethyl]amino}-3-oxopropyl)amino]-3-hydroxy-2,2-dimethyl-4-oxobutyl} diphosphate) | chebi:57288 | |
| Acetyl-CoA | acetyl-CoA | 3'-phosphonatoadenosine 5'-(3-{(3R)-4-[(3-{[2-(acetylsulfanyl)ethyl]amino}-3-oxopropyl)amino]-3-hydroxy-2,2-dimethyl-4-oxobutyl} diphosphate) | chebi:57288 | |
| Oxaloacetate | oxaloacetate | 2-oxobutanedioate | chebi:16452 | |
| TCA | TCA | trichloroacetic acid | chebi:30956 | |
| Citrate | citrate | chebi:133748 | ||
| CoA | CoA | 3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl] diphosphate} | chebi:57287 | |
| COASH | CoASH | 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl] dihydrogen diphosphate} | chebi:15346 | |
| Citrate | citrate | chebi:133748 | ||
| CTP | CTP | CTP | chebi:37563 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|